Sendero Wealth Management LLC raised its position in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 7.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 12,261 shares of the company’s stock after buying an additional 898 shares during the period. Sendero Wealth Management LLC’s holdings in Henry Schein were worth $848,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. Cromwell Holdings LLC grew its stake in shares of Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after purchasing an additional 170 shares during the last quarter. Versant Capital Management Inc boosted its holdings in Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after buying an additional 335 shares in the last quarter. City State Bank acquired a new position in Henry Schein in the fourth quarter worth approximately $55,000. Farther Finance Advisors LLC increased its holdings in shares of Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after buying an additional 346 shares in the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt lifted its position in shares of Henry Schein by 282.1% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after acquiring an additional 1,100 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.
Henry Schein Price Performance
Shares of NASDAQ:HSIC opened at $71.15 on Thursday. The firm has a market cap of $8.87 billion, a price-to-earnings ratio of 29.28, a P/E/G ratio of 1.90 and a beta of 0.89. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.63. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The business has a fifty day simple moving average of $72.18 and a 200 day simple moving average of $70.57.
Analyst Ratings Changes
A number of brokerages recently issued reports on HSIC. Evercore ISI lifted their target price on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price on the stock. Barrington Research restated an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a report on Wednesday, November 6th. Finally, StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Seven investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $79.40.
Read Our Latest Research Report on HSIC
Insider Buying and Selling at Henry Schein
In other news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.14% of the company’s stock.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading
- Five stocks we like better than Henry Schein
- What is a Stock Market Index and How Do You Use Them?
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- Compound Interest and Why It Matters When Investing
- How Do Stock Buybacks Affect Shareholders?
- The Basics of Support and Resistance
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.